Falsified Amoxicillin + Clavulanic Acid products circulating in Haiti
This Medical Product Alert relates to two confirmed falsified versions of amoxicillin + clavulanic acid products circulating in Haiti, presented under the names “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav”.
Genuine amoxicillin + clavulanic acid is used to treat a range of bacterial infections and is referenced on the WHO Essential Medicines List as an access group antibiotic.
WHO was informed by the Haiti Ministère de la Santé Publique et de la Population (MSPP) and Caribbean Public Health Agency’s (CARPHA) VigiCarib network (which is a regional reporting system for pharmacovigilance and post market surveillance), that falsified “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav” were found in a pharmacy in Haiti. At this stage, laboratory testing of these products is being facilitated. Product details are listed in the tables below.
1. Augmentin and Amoxicillin Clavulanate Potassium
Table 1: Details of the falsified product Augmentin and Amoxicillin Clavulanate Potassium, subject of WHO medical product alert N°11/2019
200728 BCH/QUAMED: Europe should lead in coordinated procurement of quality- assured medicines Be-cause Health & QUAMED literature updates
31 July 2020